pd1
Merck lines up early-stage Keytruda combo trial
April 1, 2015Research and Development, Sales and Marketing Cancer, Merck, entinostat, keytruda, pd1, pembrolizumab, syndax
Merck is planning for Keytruda’s future by launching early-stage trials of the drug in combination with an investigational treatment from …
Merck and Eisai partner on cancer therapy trial
March 6, 2015Research and Development, Sales and Marketing Bayer, Cancer, FDA, Halaven, Lenvima, Merck, Stivarga, keytruda, oncology, pd1
Merck and Eisai are teaming up for collaborative trials to test the effects of using combinations of each company’s oncology …
Boehringer pays $600m for cancer vaccine deal
September 19, 2014Research and Development, Sales and Marketing Boehringer Ingelheim, cancer vaccine, oncology, pd1
Boehringer is hoping to expand its oncology pipeline with a new multi-million dollar pact for an investigational cancer vaccine. The …
MedImmune to work with biotech Advaxis on cancer
July 22, 2014Research and Development, Sales and Marketing Advaxis, AstraZeneca, Cancer, MEDI4736, MedImmune, oncology, pd1
AZ’s MedImmune has entered into a clinical trial collaboration with US biotech firm Advaxis to help develop new cancer immunotherapies. …
Latest content
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
